Urothelial Cancers Phase 3 Trial KEYNOTE-045 and KEYNOTE-361 Efficacy and Safety Results Bladder 3 Mins Read0 Patrizia Giannatempo, MD, from the Fondazione IRCCS Istituto Nazionale dei Tumori, has conducted extensive research on the impact of histology…
